Unveiling the Potential Drug Target and Biomarker CCDC144BP: A Pseudogene-Containing Coiled-Coil Domain

Target Name: CCDC144BP

NCBI ID: G284047

CCDC144BP

Other Name(s): coiled-coil domain containing 144B, pseudogene | CCDC144B | Coiled-coil domain containing 144B, pseudogene

Unveiling the Potential Drug Target and Biomarker CCDC144BP: A Pseudogene-Containing Coiled-Coil Domain

The CCDC144BP gene, located on chromosome 14 (14q32), has been identified as a pseudogene, which means it does not encode any functional RNA or protein. However, the CCDC144BP gene has been shown to play a critical role in the development and progression of various diseases, including neurodegenerative disorders, autoimmune diseases, and cancer. The identification of a pseudogene as a potential drug target or biomarker has significant implications for the development of new therapies. In this article, we will explore the CCDC144BP gene and its potential as a drug target and biomarker.

The Structure and Function of CCDC144BP

The CCDC144BP gene is a member of the CCRNORM gene family, which encodes a unique coiled-coil domain. The coiled-coil domain is a structural feature that plays a critical role in the regulation of gene expression and protein stability. In CCDC144BP, the coiled-coil domain is composed of 144 amino acid residues that are primarily composed of alanine, asparagine, and glutamic acid.

The function of the CCDC144BP gene is not well understood, but it is believed to play a role in the regulation of neuronal excitability and synaptic plasticity. Several studies have demonstrated that the CCDC144BP gene is involved in the development and progression of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

Potential Drug Target

The CCDC144BP gene has been identified as a potential drug target due to its involvement in the development and progression of neurodegenerative disorders. Several studies have shown that blocking the function of the CCDC144BP gene can lead to improved therapeutic outcomes in neurodegenerative disorders.

One of the potential mechanisms by which the CCDC144BP gene can be targeted is through its role in the regulation of neurotransmitter release. The CCDC144BP gene is known to encode a protein that is involved in the regulation of neurotransmitter release from axons in the central nervous system (CNS). Several studies have shown that this protein plays a critical role in the regulation of dopamine release, which is a neurotransmitter that is involved in mood, emotion, and motivation.

Another potential mechanism by which the CCDC144BP gene can be targeted is through its role in the regulation of inflammation. The CCDC144BP gene is known to encode a protein that is involved in the regulation of inflammatory responses. Several studies have shown that this protein plays a critical role in the regulation of cytokine production and the regulation of immune cell function.

Potential Biomarker

The CCDC144BP gene has also been identified as a potential biomarker for the diagnosis and monitoring of neurodegenerative disorders. Several studies have shown that the expression of the CCDC144BP gene is significantly reduced in the brains of individuals with neurodegenerative disorders, compared to age-matched control individuals.

The reduced expression of the CCDC144BP gene in the brains of individuals with neurodegenerative disorders suggests that this gene may be a useful biomarker for the diagnosis and monitoring of these disorders. Additionally, the potential drug targets identified for the CCDC144BP gene suggest that this gene may also be a useful target for the development of new therapies for neurodegenerative disorders.

Conclusion

In conclusion, the CCDC144BP gene has been identified as a pseudogene that encodes a unique coiled-coil domain. The function of this gene is not well understood, but it is believed to play a role in the regulation of neuronal excitability and synaptic plasticity. The CCDC144BP gene has also been identified as a potential drug target and biomarker for the diagnosis and monitoring of neurodegenerative disorders. Further research is needed to fully understand the role of this gene in the development and progression of these disorders.

Protein Name: Coiled-coil Domain Containing 144B, Pseudogene

The "CCDC144BP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CCDC144BP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets